Organometallics
Article
1
127.1 (o-C(2,6‑xylyl)), 125.3 (NCCHCH), 123.9 (p-CH(2,6‑xylyl)), 116.3
(NCCHCH), 19.5 (CH3(imine)), 19.1 (o-CH3(2,6‑xylyl)). FTIR (neat)
νCN 1668, 1653 cm−1. Anal. Calcd for C27H28CuIN4: C, 54.14; H,
4.71; N, 9.35. Found: C, 53.97; H, 4.54; N, 9.08.
(594 mg, 1.45 mmol, 57%). H NMR (400 MHz, CDCl3): δ 9.93 (s,
1H, NCHN), 7.07 (d, 3J = 7.5 Hz, 4H, m-CH(2,6‑xylyl)), 6.98 (t, 3J = 7.5
3
Hz, 2H, p-CH(2,6‑xylyl)), 4.34 (t, J = 5.7 Hz, 4H, NCH2CH2), 2.59 (s,
6H, CH3(imine)), 2.47 (p, 3J = 5.7 Hz, 2H, NCH2CH2), 2.07 (s, 12H, o-
CH3(2,6‑xylyl)). 13C{1H} NMR (100 MHz, CDCl3): δ 154.1 (NCN),
153.7 (CN), 144.5 (Cipso(2,6‑xylyl)), 128.4 (m-CH(2,6‑xylyl)), 126.5 (o-
C(2,6‑xylyl)), 124.5 (p-CH(2,6‑xylyl)), 42.2 (NCH2CH2), 18.7 (NCH2CH2),
18.5 (o-CH3(2,6‑xylyl)), 15.9 (CH3(imine)). FTIR (neat) νCN 1628 cm−1.
[1,3-Bis[1-(2,6-dimethylphenylimino)ethyl]-4,5,6-trihydro-
pyrimidin-2-ylidene]copper(I) Iodide (3b). Sodium hexamethyldi-
silazide (50.7 mg, 0.276 mmol) was dissolved in THF (4 mL) and
added dropwise to a THF (4 mL) suspension of copper iodide (52.1
mg, 0.274 mmol) at −37 °C. The reaction mixture was stirred for 30
min, and it was then added dropwise to a THF (5 mL) suspension of
1,3-bis[1-(2,6-dimethylphenylimino)ethyl]-4,5,6-trihydropyrimidinium
chloride (2b; 112 mg, 0.273 mmol) at −37 °C. The reaction mixture
was slowly warmed to room temperature and stirred for an additional
4 h. Pentane was added to precipitate a brown solid, and the
supernatant was removed. The volatiles were removed in vacuo to give
the product in 76% yield (118 mg, 0.208 mmol). 1H NMR (400 MHz,
[1,3-Bis[1-(2,6-dimethylphenylimino)ethyl]benzimidazol-2-
ylidene]chromium(III) Chloride (4a). To a mixture of CrCl3·3THF
(39.4 mg, 0.105 mmol) and 1,3-bis[1-(2,6-dimethylphenylimino)-
ethyl]benzimidazol-2-ylidene copper(I) iodide (3a; 62.9 mg, 0.105
mmol) was added 10 mL of dichloromethane at room temperature.
The reaction mixture was stirred overnight and subsequently filtered.
The solvent was removed in vacuo. The solid was then dissolved in
toluene and filtered. The filtrate was collected, and the solvent was
removed in vacuo to give a blue-green solid in 71% yield (42.5 mg,
0.0750 mmol). FTIR (neat): νCN 1683, 1622 cm−1. μeff = 3.75 μB.
Anal. Calcd for C27H28CrCl3N4: C, 57.20; H, 4.98; N, 9.88. Found: C,
56.94; H, 4.98; N, 10.10.
[1,3-Bis[1-(2,6-dimethylphenylimino)ethyl]benzimidazol-2-
ylidene]iron(II) Chloride (5a). Potassium hexamethyldisilazide (65.6
mg, 0.329 mmol) was dissolved in THF (4 mL) and added dropwise
to a THF (8 mL) suspension of iron(II) chloride (41.4 mg, 0.327
mmol) at −37 °C. The reaction mixture was slowly warmed to room
temperature and stirred for 40 min, filtered, and added dropwise to a
THF (5 mL) suspension of 1,3-bis[1-(2,6-dimethylphenylimino)-
ethyl]benzimidazolium chloride (2a; 144 mg, 0.323 mmol) at −37 °C.
The reaction mixture was slowly warmed to room temperature and
stirred for an additional 22 h. The reaction mixture was filtered, and
the solution was concentrated to about 1 mL. Pentane was added to
precipitate a yellow solid. The supernatant was removed, and the
residual solid was dried to give the product in 71% yield (122 mg,
0.228 mmol). FTIR (neat): νCN 1683, 1629 cm−1. μeff = 5.86 μB.
Anal. Calcd for C27H28FeCl2N4: C, 60.58; H, 5.27; N, 10.47. Found:
C, 60.30; H, 5.02; N, 10.15.
[1,3-Bis[1-(2,6-dimethylphenylimino)ethyl]benzimidazol-2-
ylidene]cobalt(II) Chloride (6a). Potassium hexamethyldisilazide
(70.2 mg, 0.352 mmol) was dissolved in THF (4 mL) and added
dropwise to a THF (8 mL) suspension of cobalt(II) chloride (45.5 mg,
0.350 mmol) at −37 °C. The reaction mixture was stirred for 40 min
at room temperature. It was then filtered, and the filtrate was added
dropwise to a THF (5 mL) suspension of 1,3-bis[1-(2,6-
dimethylphenylimino)ethyl]benzimidazolium chloride (2a; 153 mg,
0.344 mmol) at −37 °C. The reaction mixture was slowly warmed to
room temperature and stirred for an additional 22 h. It was filtered,
and the solution was concentrated to about 1 mL. Pentane was added
to precipitate the product as a green solid in 62% yield (115 mg, 0.344
mmol). FTIR (neat): νCN 1683, 1607 cm−1. μeff = 4.27 μB. Anal.
Calcd for C27H28CoCl2N4: C, 60.23; H, 5.24; N, 10.41. Found: C,
60.50; H, 5.02; N, 10.18.
3
3
CD3CN): δ 7.09 (d, J = 7.7 Hz, 4H, m-CH(2,6‑xylyl)), 6.97 (t, J = 7.7
Hz, 2H, p-CH(2,6‑xylyl)), 3.69 (t, J = 6.5 Hz, 4H, NCH2CH2), 2.28 (s,
3
3
12H, o-CH3(2,6‑xylyl)), 2.27 (m, J = 6.5 Hz, 2H, NCH2CH2), 1.99 (s,
6H, CH3(imine)). 13C{1H} NMR (100 MHz, CD3CN): δ 162.3 (NCN),
146.1 (CN), 130.3 (o-C(2,6‑xylyl)), 128.9 (m-CH(2,6‑xylyl)), 128.8
(Cipso(2,6‑xylyl)), 125.2 (p-CH(2,6‑xylyl)), 46.1 (NCH2CH2), 23.3
(NCH2CH2), 20.0 (o-CH3(2,6‑xylyl)), 16.8 (CH3(imine)). FTIR (neat)
νCN 1635 cm−1. Anal. Calcd for C24H30CuIN4: C, 51.02; H, 5.35; N,
9.92. Found: C, 50.87; H, 5.16; N, 9.65.
[1,3-Bis[1-(2,6-dimethylphenylimino)ethyl]-4,5,6-trihydro-
pyrimidin-2-ylidene]chromium(III) Chloride (4b). A dichloro-
methane solution of CrCl3·3THF (37.5 mg, 0.100 mmol) was added,
at room temperature, to a dichloromethane suspension of 1,3-bis[1-
(2,6-dimethylphenylimino)ethyl]-4,5,6-trihydropyrimidin-2-ylidene
copper(I) iodide (3b; 56.7 mg, 0.100 mmol). The reaction mixture
was stirred for 20 h and subsequently filtered. The filtrate was
collected, and the solvent was removed in vacuo to give a light blue-
green solid. Yield: 45.9 mg, 0.0861 mmol, 86%. X-ray-quality crystals
were grown from a concentrated dichloromethane solution of 4b by
slow evaporation of the solvent. FTIR (neat): νCN 1623 cm−1. μeff
=
4.14 μB. Anal. Calcd for C24H30CrCl3N4: C, 54.09; H, 5.67; N, 10.51.
Found: C, 54.57; H, 5.81; N, 9.96.
[1,3-Bis[1-(2,6-dimethylphenylimino)ethyl]-4,5,6-trihydro-
pyrimidin-2-ylidene]iron(II) Chloride (5b). Potassium hexame-
thyldisilazide (51.6 mg, 0.259 mmol) was dissolved in THF (4 mL)
and added dropwise to a THF (4 mL) suspension of iron(II) chloride
(32.5 mg, 0.256 mmol) at −37 °C. The reaction mixture was kept at
−37 °C for 3 h and agitated occasionally. It was then filtered, and the
filtrate was added dropwise to a THF (4 mL) suspension of 1,3-bis[1-
(2,6-dimethylphenylimino)ethyl]-4,5,6-trihydropyrimidinium chloride
(2b; 101 mg, 0.245 mmol) at −37 °C. The reaction mixture was
slowly warmed to room temperature and stirred for an additional 20 h.
The mixture was then concentrated, and pentane was added to
precipitate a reddish solid. The solid was dissolved in dichloromethane
and then filtered. The volatiles were removed in vacuo to give the
product in 81% yield (123 mg, 0.245 mmol). FTIR (neat): νCN 1638,
1617 cm−1. μeff = 5.80 μB. Anal. Calcd for C24H30FeCl2N4: C, 57.50; H,
6.03; N, 11.18. Found: C, 57.21; H, 5.75; N, 10.89.
[1,3-Bis[1-(2,6-dimethylphenylimino)ethyl]-4,5,6-trihydro-
pyrimidin-2-ylidene]cobalt(II) Chloride (6b). Potassium hexame-
thyldisilazide (46.6 mg, 0.234 mmol) was dissolved in THF (4 mL)
and added dropwise to a THF (4 mL) suspension of cobalt chloride
(30.4 mg, 0.232 mmol) at −37 °C. The reaction mixture was kept at
−37 °C for 3 h and agitated occasionally. It was then filtered, and the
filtrate was added dropwise to a THF (4 mL) suspension of 1,3-bis[1-
(2,6-dimethylphenylimino)ethyl]-4,5,6-trihydropyrimidinium chloride
(2b; 90.0 mg, 0.219 mmol) at −37 °C. The reaction mixture was
slowly warmed to room temperature and stirred for an additional 20 h.
The mixture was then concentrated, and pentane was added to
precipitate a green solid. The solid was dissolved in dichloromethane
(1-(2,6-Dimethylphenylimino)ethyl)-4,5,6-trihydropyrimi-
dine (1b). N-(2,6-Dimethylphenyl)acetimidoyl chloride (100 mg,
0.554 mmol) was dissolved in toluene (3 mL) and added to a toluene
solution (3 mL) of 1,4,5,6-tetrahydropyrimidine (90.6 mg, 1.10 mmol)
at room temperature. The reaction mixture was stirred for 16 h. The
mixture was filtered, and the solvent was removed in vacuo to give the
1
product as a light yellow oil (111 mg, 87%). H NMR (300 MHz,
CDCl3): δ 7.89 (s, 1H, NCHN), 7.03 (d, 3J = 7.4 Hz, 2H, m-
3
3
CH(2,6‑xylyl)), 6.88 (t, J = 7.4 Hz, 1H, p-CH(2,6‑xylyl)), 3.88 (t, J = 6.0
Hz, 2H, CNCH2CH2), 3.49 (t, 3J = 6.0 Hz, 2H, CNCH2CH2), 2.02
3
(s, 6H, o-CH3(2,6‑xylyl)), 1.96 (tt, J = 6.0 Hz, 2H, NCH2CH2), 1.88 (s,
3H, CH3(imine)). 13C{1H} NMR (75.5 MHz, CDCl3): δ 152.4 (CN),
146.7 (Cipso(2,6‑xylyl)), 143.8 (NCN), 127.7 (m-CH(2,6‑xylyl)), 127.2 (o-
C(2,6‑xylyl)), 122.3 (p-CH(2,6‑xylyl)), 44.3 (CNCH2CH2), 41.0
(NCH2CH2), 20.9 (NCH2CH2), 18.0 (o-CH3(2,6‑xylyl)), 14.2
(CH3(imine)).
1,3-Bis[1-(2,6-dimethylphenylimino)ethyl]-4,5,6-trihydro-
pyrimidinium Chloride (2b). N-(2,6-Dimethylphenyl)acetimidoyl
chloride (462 mg, 2.54 mmol) was dissolved in 8 mL of benzene and
added to a solution of (1-(2,6-dimethylphenylimino)ethyl)-4,5,6-
trihydropyrimidine (1b; 583 mg, 2.54 mmol) in benzene (10 mL)
at room temperature. The reaction mixture was stirred for 20 h. The
white solid was washed with toluene and pentane and dried in vacuo
7356
dx.doi.org/10.1021/om300873k | Organometallics 2012, 31, 7351−7358